Tactile Medical Prepares for Third Quarter Results Release
Upcoming Financial Results Announcement
Tactile Systems Technology, Inc., known as Tactile Medical (NASDAQ: TCMD), is gearing up to share its financial results for the third quarter of fiscal year 2024. This highly anticipated announcement is scheduled for release after the market closes on the designated day in November.
Details of the Conference Call
Following the release of financial results, Tactile Medical invites stakeholders and interested parties to join a conference call. Set to occur at 5:00 p.m. Eastern Time, this session will include a comprehensive review of the quarterly outcomes complemented by a question and answer segment. Participants can connect easily by dialing the specified toll-free numbers, with international callers able to join through a designated line.
Accessibility of the Conference
For those unable to attend the live session, Tactile Medical ensures accessibility by offering a replay of the call for two weeks post-event. Additionally, the call will be archived, allowing stakeholders to access the information at their convenience via the company’s investor relations website.
About Tactile Medical
Tactile Medical stands out as a pioneering entity in providing innovative, at-home therapies designed for individuals grappling with chronic health conditions. With a focus on lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease, Tactile Medical is dedicated to enhancing its patients' quality of life.
Commitment to Patient Care
The company partners with healthcare clinicians to bolster medical evidence surrounding these conditions, striving to improve awareness and enhance patient access to essential care. By doing so, Tactile Medical works to alleviate the financial burden of chronic health issues while promoting a higher standard of living for its patients.
How to Stay Updated
Investors interested in staying informed on Tactile Medical’s developments are encouraged to reach out to Sam Bentzinger from the Gilmartin Group for inquiries. Tactile Medical’s commitment not only lies in delivering superior therapies but also in ensuring transparency and engagement with its investor community.
Frequently Asked Questions
When will Tactile Medical release its financial results?
Tactile Medical is set to release its financial results for the third quarter of fiscal year 2024 after the market closes on November 4.
How can I participate in the conference call?
Interested individuals can participate in the conference call by dialing 877-407-3088 for U.S. callers or 201-389-0927 for international participation.
Will the call be available later?
Yes, a replay of the call will be available for two weeks after the event, making it convenient for those who cannot attend live.
What is Tactile Medical's primary focus?
Tactile Medical focuses on developing therapies for chronic conditions such as lymphedema and chronic pulmonary diseases, helping patients manage their health at home.
Who can I contact for investor inquiries?
For investor inquiries, contact Sam Bentzinger at the Gilmartin Group via email for more information and assistance.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.